Evidence map›Paper›PMID 27054698›Full record

ArticlePloS one2016

Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?

Sandar Tin Tin, J Mark Elwood, Ross Lawrenson, Ian Campbell, Vernon Harvey, Sanjeewa Seneviratne

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disparities in Non-Fatal Health Outcomes in Pediatric General Trauma Studies.International journal of environmental research and public health · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sandar Tin TinSection of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.
J Mark ElwoodSection of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.
Ross LawrensonWaikato Clinical School, University of Auckland, Hamilton, New Zealand.
Ian CampbellWaikato Clinical School, University of Auckland, Hamilton, New Zealand.
Vernon HarveyAuckland District Health Board, Auckland, New Zealand.
Sanjeewa SeneviratneWaikato Clinical School, University of Auckland, Hamilton, New Zealand.
University of Auckland · NZAuckland District Health Board · NZUniversity of Colombo · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients who received private health care appear to have better survival from breast cancer compared to those who received public care. This study investigated if this applied to New Zealand women and identified factors that could explain such disparities.

methodsThis study involved all women who were diagnosed with primary breast cancer in two health regions in New Zealand, covering about 40% of the national population, between June 2000 and May 2013. Patients who received public care for primary treatment, mostly surgical treatment, were compared with those who received private care in terms of demographics, mode of presentation, disease factors, comorbidity index and treatment factors. Cox regression modelling was performed with stepwise adjustments, and hazards of breast cancer specific mortality associated with the type of health care received was assessed.

resultsOf the 14,468 patients, 8,916 (61.6%) received public care. Compared to patients treated in private care facilities, they were older, more likely to be Māori, Pacifika or Asian and to reside in deprived neighbourhoods and rural areas, and less likely to be diagnosed with early staged cancer and to receive timely cancer treatments. They had a higher risk of mortality from breast cancer (hazard ratio: 1.95; 95% CI: 1.75, 2.17), of which 80% (95% CI: 63%, 100%) was explained by baseline differences, particularly related to ethnicity, stage at diagnosis and type of loco-regional therapy. After controlling for these demographic, disease and treatment factors, the risk of mortality was still 14% higher in the public sector patients.

conclusionsEthnicity, stage at diagnosis and type of loco-regional therapy were the three key contributors to survival disparities between patients treated in public and private health care facilities in New Zealand. The findings underscore the need for more efforts to improve the quality, timeliness and equitability of public cancer care services.

Indexed as

Delivery of Health CareHospitals, PrivateHospitals, PublicBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularCombined Modality TherapyErb-b2 Receptor Tyrosine KinasesEthnicityFemaleHumansMiddle AgedNeoplasm GradingNeoplasm StagingPrognosisProspective StudiesERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID27054698
PMCPMC4824501
OpenAlexW2312206019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.